Today’s health benefits professional needs to make critical and informed decisions to better manage the higher cost of specialty drugs inclusive of biopharma drugs and solutions (i.e. biologics, biosimilars, pharmacogenomics, gene therapies).

This toolkit provides guidance, knowledge and access to no-cost resources to support plan performance and cost management efforts, and includes ways to optimize specialty drug use in the medical and pharmacy benefit, make informed decisions on benefit coverage approaches and address PBM transparency issues on pricing, rebates and contracting.